Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Melanoma 11 Triple Negative Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Neoplasms 7 Head and Neck Neoplasms 7 Multiple Myeloma 6 Carcinoma, Transitional Cell 6 Carcinoma, Renal Cell 6 Pancreatic Neoplasms 5 Lung Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Stomach Neoplasms 2 Sarcoma 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Kidney Neoplasms 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 Glioblastoma 2 Urothelial Cancer 1 Thyroid Neoplasms 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinocerebellar Degenerations 1

Interventions

pembrolizumab 1 nirogacestat 1 lenvatinib 1 Palliative Care 1 Nutritional Support 1 Celecoxib 1 Analgesia 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Sarcoma, Kaposi × pembrolizumab × Clear all

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡